.

Friday, April 5, 2019

Effect of Adolescent Cannabis Use on Brain Functions

Effect of puerile ganja Use on encephalon Functions hemp Use During Adolescence A Review of Impacts on Brain Functions and Associated OutcomesRecent years stand seen a dramatic change magnitude in the social acceptability of hemp us age in the United States, with several(prenominal) states having already legalized recreational delectation of the substance and several more projected to do so in spite of appearance the next several years (Leyton, 2016). Concurrently, there has been an increase in the amount of teenages who report using hangmans rope, with young data indicating that 39% of high school seniors report using hangmans halter within the past year and 6-7% reporting daily or near daily hempen necktie custom (Johnston & OMalley, 2015). Despite increase utilization of hempen necktie products for pain management and other ailments (Hwang & Clarke, 2016), some in the scientific community give expressed concern about the potential ramifications of recreational leg alization of ganja. Chief amongst these concerns is the idea that teenagers will assimilate very easy access to increasingly potent halter and synthetic cannabis products (Sobesky & Gorgens, 2016), as a great deal of research has contendd that the drug ab apply of cannabis lodges several risk of infections specific to individuals in the adolescent age range (see Levine, Clemenza, Rynn, & Lieberman, 2017). This paper will summarize the research examining the stir of cannabis phthisis on the growth adolescent witticism and potential associated outcomes, peculiarly in the atomic number 18as of cognition/executive function, anxiety and depression, psychotic disorders, and ahead of time substance substance ab affair/dependence. The Adolescent Brain To understand the impact of cannabis accustom on the developing adolescent brain, it is first necessary to understand the changes taking place in the brain during this instructional compass point. non surprisingly, the close of adolescence is a cadence of tremendous change in the circuitry of the brain. According to Arain et al. (2013), there is a world-shaking amount of neuronal plasticity in the brain during adolescence, meaning the wiring of the brain is extremely universal to learning and implement. Such plasticity, particularly in the prefrontal cortex, lends itself to difficulty thinking rationally and critically, often preeminent to the impulsive decision-making that is characteristic of the adolescent years. In addition, the hypothalamic pituitary adrenal (HPA) axis, the schema responsible for regulation human responses to separate out, similarly undergoes substantial discipline during the transaction of adolescence. Within this system, the amount and duration of adrenocorticotropic horm adept (ACTH) and glucocorticoids released in response to stress increase significantly as comp bed to other life periods (Romeo, 2013). Shortly in the top out puberty, a surge ofsynapto in gredientsis and neuronal growth occurs in which grey matter in the brain thickenssubstantially. From this focalisethroughout the period of adolescence, the brain is continually rewired throughdendritic pruning and change magnitude myelination of synapses, particularly in theprefrontal cortex (Arain et al., 2013 Lubman, Bonomo, & Yucel, 2007). In addition, white matter increases are seenin the corpus callosum (Arain et al., 2013).Taken together, these changes increase the efficiency of communicationwithin the brain, allowing for the eventual schooling of more thickeningcognitive functioning, including improved longing acquire got, operationalthinking, and working memory (Hart, 2007 Lubman et al., 2007). In addition to the constant rewiring of braincircuitry that occurs during adolescence, the levels of three neurotransmitters dopamine, serotonin, and melatonin change during the adolescent period(Arain et al., 2013). According to Dahl(2003), dopamine and serotonin levels decr ease during adolescence, resulting in mad dysregulation, mood disruptions, and difficulties with beatcontrol. Melatonin levels, on the otherhand, increase, which in turn increases the amount of sleep that adolescentsneed to be fully re-charged. accustomed the massive changes that are occurring inthe brain during the period of adolescence, it is a time in which the brain is in particular susceptible to the employ of substances, (Lubman et al., 2007) includingcannabis. marijuana Action in the BrainBefore discourseing the specific impacts ofcannabis do on the adolescent brain, it is important to understand howcannabis acts in the brain in constituentral.First, the brain has an endogenous cannabinoid system (endocannabinoidsystem) made up of the ligands anandamide and 2-arachidonoyl glycerol (2-AG)and cannabinoid sensory receptors known as CB1 and CB2 receptors (Moreira & Lutz,2008). CB1 receptors are locatedthroughout the brain, only are particularly populous in the front r egion of thecerebral cortex, the basal ganglia, the cerebellum, the hypothalamus, theanterior cingulate cortex, and the genus Hippocampus CB2 receptors are generally comprise throughout the bodys immune system (Hill et al., 2010 Iversen,2004). The endocannabinoid system manoeuvresa role in a number of processes, including the regulation of the HPA axisstress response (Hill et al., 2010 Lee & Gorzalka, 2015), spookyplasticity, and learning and memory (Lu et al., 2008). According to Iversen (2004), thepsychoactive component in cannabis is 9-tetrahydrocannabinol (THC). THC, as well as increasingly popularsynthetic cannabinoids, act as agonists on CB1 cannabinoid receptors in thebrain. Because CB1 receptors aregenerally presynaptic sort of than postsynaptic, cannabinoids control therelease of certain neurotransmitters, including acetylcholine, L-glutamate,-amino neverthelessyric acid (GABA), noradrenaline (norepinephrine), dopamine, and5-hydroxytryptamine (5-HT). The use ofexogenous c annabinoids, much(prenominal) as marijuana or synthetic marijuana products,leads to an unnaturally long-lasting activation of CB1 receptors, ultimatelyinhibiting the release of the aforesaid(prenominal) neurotransmitters in selectedareas of the brain (Iversen, 2004). Inaddition to its impact on CB1 receptors and associated neurotransmitters, THC in like mannerappears to trigger the touchwood of dopaminergic neurons in the ventral teg psychicalarea of the brain and the nucleus accumbens areas of the brain that areheavily implicated in the brains reward circuit associated with drug use. This effect is also seen with heroin,cocaine, amphetamines, and nicotine, suggesting that THC may also act on theopioid receptor system within the brain (Iversen, 2004).Impact on Cognition and executive director Function TasksThe literature has focuse on severallarger areas of impact regarding cannabis use during adolescence, one of thesebeing the potential impacts on cognition and tasks of execu tive function. As precedingly mentioned, the brain undergoesa significant amount of change in the adolescent years, including the frequentre-wiring of neural connections through neural pruning processes, particularlyin the prefrontal cortex. According toFilbey, McQueeny, DeWitt, and Mishra (2015), cannabis use during adolescencedisrupts this normal pruning process through its flection ofneurotransmitters and inhibition of microglial processes. This results in abnormal connectivity withinthe brain, including a decrease in white matter raft and integrity (Gruber,Dahlgren, Sagar, Gonenc, & Lukas, 2014 Jacobus et al., 2009). Such changesresult in a number of cognitive impacts, including change magnitude impulsivity,poorer reaction times, and increase errors on executive function tasks (e.g.,planning, organization, self-regulation, etc.) (Becker, Wagner,Gouzoulis-Mayfrank, Spuentrup, & Daumann, 2010 Gruber et al., 2014). Indeed, studies have indicated thatindividuals who begin mariju ana use in early adolescence are at an increasedrisk for developing deficits in attention (Ehrenreich et al., 1999) and visualprocessing (Tapert, Granholm, Leedy, & Brown, 2002), and exhibit areduced full scale IQ and verbal IQ in swelledhood (Meier et al., 2012). Memory also appears to be abnormal by adolescent-onset cannabis use (Tait, Mackinnon, & Christensen, 2011), likely via its impact on the genus Hippocampus a part of the brain heavily implicated in memory functions. Animal research has shown that the hippocampus is affected by cannabis use peculiarly during the period of adolescence. In rats, adolescent picture show to cannabis force the microstructure of the hippocampus as well as abnormalities in the way that proteins are expressed in the hippocampus (Quinn et al., 2008). Specifically, it appears that exogenous cannabinoids bind to CB1 receptors and inhibit the release of glutamate, thus contributing to deficits in short-term memory (Hart, 2007) and disallowly impa cting performance on memory-related tasks (see Levine et al., 2017). Some animal studies indicate that lower levels of cannabis use (those most thoughtful of the actual amount that adolescents use) are not predictive of long-lasting hippocampal changes. However, because current cannabis products are go along to increase in potency (Levine et al., 2017), hippocampal changes and subsequent memory problems are topics of concern, especially with regard to adolescent users of cannabis. working(a) memory also appears to be impactedby cannabis use, particularly in individuals that began using cannabis beforethe age of 16. Becker et al. (2010)used functional magnetic resonance imaging to examine performance on a workingmemory task in individuals who began using cannabis before age sixteen(early-onset) as compared to individuals who began using cannabis after the ageof sixteen (after-onset). Results ofthis domain indicated that early-onset cannabis users exhibited increasedcortical acti vity in the parietal lobe as compared to later-onset cannabisusers. The researchers concluded thatthis increased cortical activity indicated change magnitude cortical efficiency inresponse to challenging working memory-related tasks in early-onset, but notlater-onset, cannabis users (Becker et al., 2010). Such findings are consistent with a number ofstudies indicating that an earlier age of onset of cannabis use is associatedwith greater risk of negative impacts on cognitive functioning during due date(Ehrenreich et al., 1999 Fontes et al., 2011 Meier et al., 2012 Pope et al.,2003). Impact on the Development of Anxiety and DepressionSeveral studies indicate a connection amidst adolescent-onset cannabis use and the development of both anxiety anddepressive disorders (e.g., Brook, Rosen, & Brook, 2001 Degenhardt et al.,2013 Fairman, 2015 Hayatbakhshet al., 2007 Patton et al., 2002 van Laar, van Dorsselaer, Monshouwer, & de Graaf, 2007).Though past researchers have speculated about t he directivity of this blood, studies have consistently indicated that adolescent-onsetdepression is not predictive of later cannabis use (e.g., Degenhardt, mansion house,& Lynskey, 2003 Moore et al., 2007 Womack, Shaw, Weaver, & Forbes,2016), negating the idea that depressive and/or anxiety notes lead toengagement in cannabis use as a method of symptom relief. Instead, such findings promote the idea that cannabisuse during adolescence, in combination with other potential risk factors,increase the risk for the development of anxiety and depressive symptoms inadulthood (Levine et al., 2017). As withthe cognitive changes discussed in the previous section of this paper, it isearly-onset use of cannabis that appears to be riskiest with regard to thedevelopment of future anxiety and depressive symptoms (Hayatbakhsh et al.,2007 Patton et al., 2002). In an arouse study by Spechler et al.(2015), fMRIs were used to examine activity in the amygdalas of adolescent usersof cannabis. The res earchers showedparticipants images of both angry and nonsubjective faces, a well-known test ofamygdala activity and a well-regarded index of emotional processing. Results of this study indicated that comparedto the control group, adolescent cannabis users exhibited increased amygdalaactivity in response to the images of angry faces whereas the control groupshowed the same amount of amygdala activity when shown images of neutralfaces. Spechler et al. (2015) concludedthat adolescent cannabis use is associated with increased hypersensitivity tonegative affect. However, in this case,the directionality of the relationship is unclear it is attainable that thesensitivity of the amygdala pre-dated the cannabis use and the cannabis use wasengaged in due to its anxiolytic effect.Conversely, it is possible that cannabis use lead to increasedsensitivity in the amygdala. Either way,it appears that adolescent cannabis users are overly sensitive to negativeaffect and the potential threat that accompanies it, which may explain theincreased incidence of depressive and anxious symptomatology in thispopulation. in that respect are several potentialneurobiological mechanisms explaining the relationship between adolescentcannabis use and the development of anxiety and depressive symptoms. One possibility is the impact of exogenouscannabinoids on the HPA axis system. Theendocannabinoid system regulates the responsivity of the HPA axis, which, asantecedently mentioned, undergoes significant development during the adolescentyears (Hill et al., 2010 Lee & Gorzalka, 2015 Romeo, 2013). Studies with both human and rodent subjectshave indicated that the use of exogenous cannabinoids during adolescence hasthe capacity to alter HPA axis stress responses, thus impacting emotionalityand the development of anxiety-related symptoms (Lee & Gorzalka, 2015).Lovelace et al. (2015) discuss another(prenominal)neurobiological mechanism that may underlie the relationship between adolescentcannabis use and the development of anxiety and depression. In a rodent study, these researchers examinedmaladaptations in the prefrontal cortex due to cannabis use by looking atpresynaptic plasticity at glutamatergic synapses in adolescent rats. The results indicated that exposure toexogenous cannabinoids during adolescence direct to over-activation of CB1receptors, which led to permanent changes in synapses in the prefrontalcortex. Overall, mice exposed toexogenous cannabinoids during adolescence showed a loss of presynapticplasticity, which impacts the brains ability to adapt to changing environmentsand thus may contribute to an increased vulnerability of psychiatry duringadulthood (Lovelace et al., 2015). In an interesting rodent study conductedby Rubino et al. (2008), researchers found that exposure to THC duringadolescence was associated with decreased density and function of CB1 receptorsin the ventral tegmental area, the nucleus accumbens, and the amygdala. These areas of the brai n are implicated inemotional processing and reward and are thus implicated in the development ofdepressive symptomatology. The behaviorof the rats in this study also mirrored depressive symptomatology. Specifically, rats exposed to THC duringadolescence exhibited both behavioral despair (which the researchers definedas time the rats were immobile) and anhedonia (as measured through decreasedconsumption of sucrose). Taken together,it appears that several neurobiological mechanisms are at play in theconnection between adolescent cannabis use and the development of anxiety anddepressive symptoms. Impact on the Development of Psychotic DisordersA substantial body of literature has indicated a connection between the use of cannabis during adolescence and the later development of psychotic disorders (e.g., van Os et al., 2002 Henquet et al., 2005 Stefanis et al., 2004). This is especially true for individuals who are already genetically predisposed to develop psychotic disorders (Henquet et al., 2005) though the connection has also been found in individuals that do not have this genetic predisposition (van Os et al., 2002). As with the impact on cognition and on anxiety/depressive symptoms, it appears that early-onset cannabis use (Arseneault et al., 2002 Moore et al., 2007) as well as heavier (i.e. daily or near-daily) use pose the greatest risk for the later development of a psychotic disorder (Moore et al., 2007 van Os et al., 2002).Rubino and Parolaro (2014) discuss the possible neurobiological mechanisms behind the connection between adolescent cannabis use and the development of psychotic disorders. In general, it appears that the use of exogenous cannabinoids during adolescence disrupts the maturational processes occurring in the brain during this time, especially in the hippocampus and the prefrontal cortex two areas of the brain that are implicated in the psychotic disorder schizophrenic disorder, in particular. The endocannabinoid system itself undergoes a significant amount of change during the adolescent years thus, exogenous cannabinoid exposure during this time period has the potential to alter the semipermanent functionality of CB1 receptors, which then impacts the activity of several neurotransmitters implicated in psychotic symptomatology, especially dopamine (Rubino & Parolaro, 2014). Additionally, being exposed to cannabis during the adolescent period has been shown to disrupt prepulse inhibition (the ability to accurately perceive and process stimuli) and down-regulate GABAergic activity in the prefrontal cortex both symptoms commonly seen in individuals with schizophrenic disorder (Morales-Muoz et al., 2014 Zamberletti et al., 2014). As previously mentioned, individuals who have a genetically predisposed vulnerability to develop psychotic disorders are at an especially high risk to do so if they engage in cannabis use during adolescence (Henquet et al., 2005). For example, individuals who have a specific variant of the g ene for catechol-O-methyltransferase (COMT), which breaks down dopamine the neurotransmitter implicated in schizophrenia are at a much higher risk for developing the disorder if they used cannabis during adolescence as compared to individuals who do not have that specific variant of the gene for COMT (Caspi et al., 2005). Another gene that influences the relationship between adolescent cannabis use and psychosis is the ATK1 gene, which affects dopamine breakdown in the striatum. According to DiForti et al. (2012), cannabis users with a certain variant of the ATK1 gene were seven times more likely to develop psychosis as compared to individuals with this gene variant who did not use cannabis. Clearly, in individuals that already possess these specific genetic variants, cannabis use during adolescence can be the trigger that leads to the expression of these genes and the development of psychotic symptoms and/or disorders. In addition, adults with psychotic disorders who used cannabi s during adolescence are at a greater risk for relapse of psychotic symptoms, poorer adherence to treatment, and increased rates of hospitalization related to their diagnosis (Hunt, Bergen, & Bashir, 2002 Lewis, Tarrier, & Drake, 2005 Wade et al., 2006). Impact on the Future Development of meat Use DisordersSeveral studies have indicated a link between adolescent cannabis use and the later development of a substance use disorder. Again, this relationship is especially strong for individuals that engage in cannabis use in early adolescence and who engage in heavy (i.e., daily or near-daily) use (Fergusson, Boden, & Horwood, 2006 Hall & Lynskey, 2005 Stuart & Green, 2008). Past researchers have speculated upon various explanations for this trend, including the so-called gateway hypothesis. In general, the gateway hypothesis assumes that individuals who use harder drugs such as heroin and cocaine almost always started their use of substances with using cannabis, and that this link is explicitly causal (Van Gundy & Rebellon, 2010). This hypothesis is based on research findings indicating that the use of cannabis during adolescence often predates the use of other outlaw(a) substances, including heroin, methamphetamines, and cocaine (Fergusson et al., 2006). Though the causality of this link has been repeatedly questioned in the literature (e.g., Morral, McCaffrey, & Paddock, 2002 Van Gundy & Rebellon, 2010), many researchers have attempted to explain the mechanisms behind the early use of cannabis and the later use of other substances and/or development of a substance use disorder. There are countless potential psychosocial explanations for this connection (e.g., mate pressure, propensity toward risk-taking behaviors, availability of substances, etc.) however, for the purposes of this paper, the potential neurobiological mechanisms behind the connection will be discussed.The major possible neurobiological mechanism behind the connection between early cannabis use and the later development of a substance use disorder has to do with the effect of cannabis on the brains opioidergic system. A great deal of animal research has indicated that the endocannabinoid system and the opioidergic system are intricately linked. For example, Pickel, Chan, Kash, Rodriguez, and Mackie (2004) and Rodriguez, Mackie, and Pickel (2001) found that CB1 receptors and opioid receptors are found on the same neurons in both the striatum and the ventral tegmental area, and Cossu et al. (2001) and Ledent et al. (1999) found that animals without CB1 receptor genes do not self-administer opioids. Drawing upon this clear connection betweenthe endocannabinoid and opioidergic brain systems, Ellgren, Spano, and Hurd(2007) investigated the hypothesis that cannabis exposure during adolescencechanges opioid-related neural functions and leads to increased likelihood of lateropioid use. Findings of this researchconfirmed that rats exposed to THC during the adolescent periodself-a dministered greater amounts of heroin compared to the control group. Moreover, findings indicated that ratsexposed to THC in adolescence showed a persistent disturbance in the activityof enkephalin, which is the endogenous opioid neuropeptide associated withreward behaviors and hedonic states. Findingsalso indicated that THC exposure led to changes in the functions of opioidreceptors such that heroin use was more reinforcing (via dopamine release) forrats exposed to THC during adolescence as compared to the control group. Taken together, these results indicate thatcannabis use during adolescence leads to a greater vulnerability to the reinforcing do of opioids during adulthood, potentially leading to a greater risk fordependence and likelihood of relapse of substance use disorders. ConclusionDespite the increasing popularity of cannabis use, both for medicinal and recreational purposes (Hwang & Clarke, 2016 Leyton, 2016), it is important to consider the resulting increased availabi lity of cannabis to individuals during the sensitive period of adolescence. Given the profound changes occurring in the brain during adolescence (Arain et al., 2013 Dahl, 2003 Hart, 2007 Lubman et al., 2007), teenagers are particularly susceptible to the influence of substances, which may lead to lasting changes in the brains functioning. Such changes are associated with poor outcomes in several areas, including deficits in performance on executive function tasks (Becker et al., 2010 Ehrenreich et al., 1999 Fontes et al., 2011 Gruber et al., 2014 Meier et al., 2012 Pope et al., 2003 Tapert et al., 2002), an increased risk for the development of anxiety and/or depressive symptoms (Brook et al., 2001 Degenhardt et al., 2013 Fairman, 2015 Hayatbakhsh et al., 2007 Patton et al., 2002 van Laar, van Dorsselaer, Monshouwer, & de Graaf, 2007), an increased risk for the development of a psychotic disorder (Arseneault et al., 2002 Caspi et al., 2005 DiForti et al., 2012 Henquet et al., 2005 M oore et al., 2007 Rubino & Parolaro, 2014 Stefanis et al., 2004 van Os et al., 2002), and an increased risk for future substance use/dependence (Fergusson et al., 2006 Hall & Lynskey, 2005 Stuart & Green, 2008). Such considerations may have important implications for policy development related to the legalization of cannabis. ReferencesArain, M., Haque, M., Johal, L., Mathur, P., Nel, W.,Rais, A., Sandu, R., & Sharma, S. (2013). Maturation of the adolescentbrain. Neuropsychiatric Disease and Treatment, 9, 13. Retrieved from http//proxyiub.uits.iu.edu/login?universal resource locator=https//search-proquest-com.proxyiub.uits.iu.edu/docview/1364721614?accountid=11620Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., &Moffitt, T. E. (2002). Cannabis use in adolescence and risk for adultpsychosis longitudinal prospective study.Bmj,325(7374),1212-1213. Retrieved from https//scholar.google.com/scholar?hl=en&as_sdt=0%2C15&q=Cannabis+use+in+adolescence+and+risk+for+adult+psychos is%3A+longitudinal+prospective+study&btnG=Becker,B., Wagner, D., Gouzoulis-Mayfrank, E., Spuentrup, E., & Daumann, J.(2010). The impact of early-onset cannabis use on functional brain correlatesof working memory.Progress in Neuro-Psychopharmacology &biological Psychiatry,34(6), 837-845. insidehttp//dx.inside.org.proxyiub.uits.iu.edu/10.1016/j.pnpbp.2010.03.032Brook,J. S., Rosen, Z., & Brook, D. W. (2001). The effect of early marijuana useon later anxiety and depressive symptoms.NYS Psychologist,13(1),35-40. Retrieved from http//proxyiub.uits.iu.edu/login? uniform resource locator=https//search-proquest-com.proxyiub.uits.iu.edu/docview/619826104?accountid=11620Caspi,A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor,A., Arseneault, L., Williams, B., Braithwaite, A., Poulton, R., & Craig, I.W. (2005). Moderation of the effect of adolescent-onset cannabis use on adultpsychosis by a functional polymorphism in the catechol-O-methyltransferasegene Longitudinal evidence of a gene X environment interaction.BiologicalPsychiatry,57(10), 1117-1127.insidehttp//dx.inside.org/10.1016/j.biopsych.2005.01.026Cossu,G., Ledent, C., Fattore, L., Imperato, A., Bhme, G. A., Parmentier, M., &Fratta, W. (2001). Cannabinoid CB1 receptor knockout mice fail toself-administer morphine but not other drugs of debauch.Behaviouralbrain research,118(1), 61-65.Dahl, R. (2003). Beyond barbaric hormones The tinderboxin the teenage brain. In Cerebrum The Dana forum on brain science, 5(3), 7-22. Retrieved from http//www.ccoso.org/sites/default/files/import/beyond-raging-hormones.pdfDegenhardt,L., Coffey, C., Romaniuk, H., Swift, W., Carlin, J. B., Hall, W. D., &Patton, G. C. (2013). The persistence of the standoff between adolescentcannabis use and common mental disorders into young adulthood.Addiction,108(1),124-133.doihttp//dx.doi.org.proxyiub.uits.iu.edu/10.1111/j.1360-0443.2012.04015.xDegenhardt,L., Hall, W., & Lynskey, M. (2003). Exploring the affiliation betwe encannabis use and depression.Addiction,98(11), 1493-1504.doihttp//dx.doi.org.proxyiub.uits.iu.edu/10.1046/j.1360-0443.2003.00437.xDiForti, M., Iyegbe, C., Sallis, H., Kolliakou, A., Falcone, M. A., Paparelli,A., Sirianni, M., La Cascia, C., Stilo, S. A., Marques, T. R., Handley, R.,Mondelli, V., Dazzan, P., Pariante, C., David, A. S., Morgan, C., Powell, J.,& Murray, R. M. (2012). Confirmation that the AKT1 (rs2494732) genotypeinfluences the risk of psychosis in cannabis users.BiologicalPsychiatry,72(10), 811-816. doihttp//dx.doi.org/10.1016/j.biopsych.2012.06.020Ehrenreich, H., Rinn, T., Kunert, H.J., Moeller, M. R., Poser, W., Schilling, L., Gigerenzer, G., & Hoehe, M.R. (1999). Specific attentional dysfunction in adults following early start ofcannabis use.Psychopharmacology,142(3), 295-301.doihttp//dx.doi.org/10.1007/s002130050892Ellgren,M., Spano, S. M., & Hurd, Y. L. (2007). Adolescent cannabis exposure altersopiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology,32(3),607-15. doihttp//dx.doi.org/10.1038/sj.npp.1301127Fairman,B. J. (2015).Contributions to the epidemiology and mental healthconsequences of cannabis smoking(Order No. AAI3619011). Availablefrom PsycINFO. (1664224820 2015-99040-239). Retrieved from http//proxyiub.uits.iu.edu/login?url=https//search-proquest-com.proxyiub.uits.iu.edu/docview/1664224820?accountid=11620Fergusson,D. M., Boden, J. M., & Horwood, L. J. (2006). Cannabis use and other illicit drug use Testing the cannabis gateway hypothesis.Addiction,101(4),556-569. doihttp//dx.doi.org/10.1111/j.1360-0443.2005.01322.xFilbey, F. M., McQueeny,T., DeWitt, S. J., & Mishra, V. (2015). Preliminary findings demonstratinglatent effects of early adolescent marijuana use onset on corticalarchitecture. Developmental Cognitive Neuroscience, 16, 16-22.doihttp//dx.doi.org.proxyiub.uits.iu.edu/10.1016/j.dcn.2015.10.001Fontes,M. A., Bolla, K. I., Cunha, P. J., Almeida, P. P., Jungerman, F., Laranjeira,R. R., Bres san, R. A., & Lacerda, A. L. T. (2011). Cannabis use before age15 and subsequent executive functioning.The British ledger ofPsychiatry,198(6), 442-447. doihttp//dx.doi.org.proxyiub.uits.iu.edu/10.1192/bjp.bp.110.077479Gruber, S. A., Dahlgren,M. K., Sagar, K. A., Gnen, A., & Lukas, S. E. (2014). Worth the waitEffects of age of onset of marijuana use on white matter and impulsivity.Psychopharmacology, 231(8), 1455-1465.doihttp//dx.doi.org.proxyiub.uits.iu.edu/10.1007/s00213-013-3326-zHall, W.D., & Lynskey, M. (2005). Is cannabis a gateway drug? testing hypothesesabout the relationship between cannabis use and the use of other illicit drugs.Drugand Alcohol Review,24(1), 39-48.doihttp//dx.doi.org/10.1080/09595230500126698Hart, H. (2007). Alcohol, drugs, andthe adolescent brain.Developmental medication and pincerNeurology,49(12), 883. Retrieved from http//proxyiub.uits.iu.edu/login?url=https//search-proquest-com.proxyiub.uits.iu.edu/docview/195605999?accountid=11620Hayatbakhsh,M. R., Najman, J. M., Jamrozik, K., Mamun, A. A., Alati, R., & Bor, W.(2007). Cannabis and anxiety and depression in young adults A largeprospective study. diary of the American Academy of Child &Adolescent Psychiatry,46(3), 408-417.doihttp//dx.doi.org.proxyiub.uits.iu.edu/10.1097/chi.0b013e31802dc54dHenquet,C., Krabbendam, L., Spauwen, J., Kaplan, C., Lieb, R., Wittchen, H., & VanOs, J. (2005). Prospective cohort study of cannabis use, predisposition forpsychosis, and psychotic symptoms in young lot.BMJ British medical checkupJournal,330(7481), 11. doihttp//dx.doi.org/10.1136/bmj.38267.664086.63Hill, M.N., Patel, S., Campolongo, P., Tasker, J. G., Wotjak, C. T., & Bains, J. S.(2010). Functional interactions between stress and the endocannabinoid systemFrom synaptic signaling to behavioral output.The Journal of Neuroscience,30(45),14980-14986. doihttp//dx.doi.org/10.1523/JNEUROSCI.4283-10.2010Hunt, G.E., Bergen, J., & Bashir, M. (2002). Medication compliance and comorbidsubstance abuse i n schizophrenia Impact on community survival 4 years after arelapse.Schizophrenia Research,54(3), 253-264.doihttp//dx.doi.org/10.1016/S0920-9964(01)00261-4Hwang,J. K., & Clarke, H. (2016). Cannabis and pain A review.Journal ofPain Management,9(4), 395-413. Retrieved fromhttp//proxyiub.uits.iu.edu/login?url=https//search.proquest.com/docview/1949290907?accountid=11620Iversen,L. (2004). How cannabis whole kit in the brain. In D. Castle, & R. Murray(Eds.),Marijuana and madness Psychiatry and neurobiology marijuanaand madness Psychiatry and neurobiology(pp. 19-40, Chapter xvi, 218Pages) Cambridge University Press, New York, NY.doihttp//dx.doi.org.proxyiub.uits.iu.edu/10.1017/CBO9780511543630.004Retrieved from http//proxyiub.uits.iu.edu/login?url=https//search-proquest-com.proxyiub.uits.iu.edu/docview/620584373?accountid=11620Jacobus,J., McQueeny, T., Bava, S., Schweinsburg, B. C., Frank, L. R., Yang, T. T.,& Tapert, S. F. (2009). White matter integrity in adolescents withhistories of m arijuana use and binge drinking.Neurotoxicology andTeratology,31(6), 349-355.doihttp//dx.doi.org/10.1016/j.ntt.2009.07.006Johnston, L. &OMalley, P.M. (2015). Monitoring theFuture National Survey Results on Drug Use, 1975-2014. Bethesda, MDNational Institute on Drug Abuse, U.S. Dept. of Health and Human Services,National Institutes of HealthLedent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J. F., Beslot,F., Bohme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P. Vassart, G.,Fratta, W., & Parmentier, M. (1999). Unresponsiveness to cannabinoids andreduced addictive effects of opiates in CB1 receptor knockout mice.Science,283(5400),401-404.Lee, T.T. Y., & Gorzalka, B. B. (2015). Evidence for a role of adolescentendocannabinoid signaling in regulating HPA axis stress responsivity andemotional behavior development. InInternational review of neurobiology(Vol.125, pp. 49-84). Academic Press.Retrieved from https//www-sciencedirect-com.proxyiub.uits.iu.edu/science/article/pii/S00747 74215000987?_rdoc=1&_fmt=high&_origin=gateway&_docanchor=&md5=b8429449ccfc9c30159a5f9aeaa92ffbLevine, A., Clemenza, K., Rynn, M.,& Lieberman, J. (2017). Evidence for the risks and consequences ofadolescent cannabis exposure.Journal of the American Academy of Child& Adolescent Psychiatry,56(3), 214-225.http//dx.doi.org.proxyiub.uits.iu.edu/10.1016/j.jaac.2016.12.014 Retrievedfrom http//proxyiub.uits.iu.edu/login?url=https//search-proquest-com.proxyiub.uits.iu.edu/docview/1875567972?accountid=11620Lewis, S. W., Tarrier, N., &Drake, R. J. (2005). Integrating non-drug treatments in early schizophrenia.TheBritish Journal of Psychiatry,187, s65-s71. doihttp//dx.doi.org/10.1192/bjp.187.48.s65Leyton, M.(2016). Legalizing marijuana. Journal of Psychiatry & Neuroscience, 41(2),75-76. http//dx.doi.org.proxyiub.uits.iu.edu/10.1503/jpn.160012 Retrieved fromhttp//proxyiub.uits.iu.edu/login?url=https//search-proquest-com.proxyiub.uits.iu.edu/docview/1819128922?accountid=11620Lovelace,J. W., Corche s, A., Vieira, P. A., Hiroto, A. S., Mackie, K., & Korzus, E.(2015). An animal model of female adolescent cannabinoid exposure elicits along-lasting deficit in presynaptic long-term plasticity.Neuropharmacology,99,242-255. doihttp//dx.doi.org/10.1016/j.neuropharm.2015.04.034Lu, A.T., Ogdie, M. N., Jrvelin, M., Moilanen, I. K., Loo, S. K., McCracken, J. T.,McGough, J. J., Yang, M. H., Peltonen, L., Nelson, S. F., Cantor, R. M., &Smalley, S. L. (2008). Association of the cannabinoid receptor gene (CNR1) withADHD and post-traumatic stress disorder.American Journal of MedicalGenetics Part B Neuropsychiatric Genetics,147b(8), 1488-1494.doihttp//dx.doi.org/10.1002/ajmg.b.30693Lubman, D., Bonomo, Y., & Yucel,M. (2007). Drug use in young peopleshort-term effects and long-term harms. In Gilvarry, E., & McArdle, P.(Eds.). Alcohol, Drugs, and Young People Clinical Approaches, Clinics inDevelopmental Medicine No. 172. London Mac Keith Press, pp. 18-50. Meier,M. H., Caspi, A., Ambler, A., Harrin gton, H., Houts, R., Keefe, R. S. E.,MacDonald, K., Ward, A., Poulton, R., & Moffitt, T. E. (2012). Persistentcannabis users show neuropsychological decline from childhood to midlife.PNAS legal proceeding of the National Academy of Sciences of the United States ofAmerica,109(40), E2657-E2664.doihttp//dx.doi.org/10.1073/pnas.1206820109Moore,T. H. M., Zammit, S., Lingford-Hughes, A., Barnes, T. R. E., Jones, P. B.,Burke, M., & Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental heath outcomes A systematic review.TheLancet,370(9584), 319-328.doihttp//dx.doi.org.proxyiub.uits.iu.edu/10.1016/S0140-6736(07)61162-3Morales-Muoz,I., Jurado-Barba, R., Ponce, G., Martnez-Gras, I., ngel Jimnez-Arriero, M.,Moratti, S., & Rubio, G. (2014). Characterizing cannabis-induced psychosisA study with prepulse inhibition of the startle reflex.PsychiatryResearch,220(1-2), 535-540. doihttp//dx.doi.org/10.1016/j.psychres.2014.08.010Moreira, F. A., & Lutz, B.(2008). The endocannabinoid s ystem Emotion, learning and addiction.AddictionBiology,13(2), 196-212.doihttp//dx.doi.org.proxyiub.uits.iu.edu/10.1111/j.1369-1600.2008.00104.xMorral,A. R., McCaffrey, D. F., & Paddock, S. M. (2002). Reassessing the marijuanagateway effect.Addiction,97(12), 1493-1504.doihttp//dx.doi.org/10.1046/j.1360-0443.2002.00280.xPatton,G. C., Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., & Hall, W.(2002). Cannabis use and mental health in younger people Cohort study.BMJBritish Medical Journal,325(7374), 1195-1198.doihttp//dx.doi.org.proxyiub.uits.iu.edu/10.1136/bmj.325.7374.1195Pickel, V. M., Chan, J., Kash, T. L., Rodriguez, J. J., & MacKie, K.(2004). Compartment-specific localization of cannabinoid 1 (CB1) and -opioidreceptors in rat nucleus accumbens.Neuroscience,127(1),101-112.Pope, H.G., Jr., Gruber, A. J., Hudson, J. I., Cohane, G., Heustis, M. A., &Yurgelun-Todd, D. (2003). Early-onset cannabis use and cognitive deficits Whatis the nature of the association?Drug and Alcohol De pendence,69(3),303-310. doihttp//dx.doi.org.proxyiub.uits.iu.edu/10.1016/S0376-8716(02)00334-4Quinn,H. R., Matsumoto, I., Callaghan, P. D., Long, L. E., Arnold, J. C.,Gunasekaran, N., Thompson, M. R., Dawson, B., Mallet, P. E., Kashem, M. A.,Mastuda-Matsumoto, H., Iwazaki, T., & McGregor, I. S. (2008). Adolescentrats find repeated -THC less aversive than adult rats but display greaterresidual cognitive deficits and changes in hippocampal protein expressionfollowing exposure.Neuropsychopharmacology,33(5), 1113-1126. doihttp//dx.doi.org/10.1038/sj.npp.1301475Rodrguez,J. J., Mackie, K., & Pickel, V. M. (2001). Ultrastructural localization ofthe CB1 cannabinoid receptor in -opioid receptor patches of the rat caudateputamen nucleus.Journal of Neuroscience,21(3), 823-833Romeo,R. D. (2013). The teenage brain The stress response and the adolescent brain.CurrentDirections in Psychological Science,22(2), 140-145.doihttp//dx.doi.org/10.1177/0963721413475445Rubino,T., & Parolaro, D. (2014). Can nabis abuse in adolescence and the risk ofpsychosis A draft review of the preclinical evidence.Progress inNeuro-Psychopharmacology & Biological Psychiatry,52, 41-44.doihttp//dx.doi.org/10.1016/j.pnpbp.2013.07.020Rubino, T., Realini, N., Guidali, C., Braida, D., Capurro, V.,Castiglioni, C., & Parolaro, D. (2008). Chronic 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in theemotional pen in adult rats behavioral and biochemical correlates.Neuropsychopharmacology,33(11),2760.Sobesky, M., &Gorgens, K. (2016). Cannabis and adolescents Exploring the substance misusetreatment provider experience in a climate of legalization. InternationalJournal of Drug Policy, 33, 66-74.http//dx.doi.org.proxyiub.uits.iu.edu/10.1016/j.drugpo.2016.02.008 Retrievedfrom http//proxyiub.uits.iu.edu/login?url=https//search-proquest-com.proxyiub.uits.iu.edu/docview/1813639780?accountid=11620Spechler, P. A., Orr, C. A., Chaarani,B., Kan, K., Mackey, S., Morton, A., Snowe, M. P., Hudson , K. E., Althoff, R.R., Higgins, S. T., Cattrell, A., Flor, H., Nees, F., Banaschewski, T., Bokde,A. L. W., Whelan, R., Buchel, C., Bromburg, U., Conrod, P., Frouin, V.,Papadopoulous, D., Gallinat, J., Heinz, A., Walter, H., Ittermann, B., Gowland,P., Paus, T., Poustka, L., Martinot, J., Artiges, E., Smolka, M. N., Schumann,G., & Garavan, H. (2015). Cannabis use in early adolescence Evidence ofamygdala hypersensitivity to signals of threat.Developmental CognitiveNeuroscience,16, 63-70.doihttp//dx.doi.org/10.1016/j.dcn.2015.08.007Stefanis, N. C., Delespaul, P.,Henquet, C., Bakoula, C., Stefanis, C. N., & Van Os, J. (2004). Earlyadolescent cannabis exposure and positive and negative dimensions of psychosis.Addiction,99(10),1333-1341. doihttp//dx.doi.org/10.1111/j.1360-0443.2004.00806.xStuart, E. A., & Green, K. M.(2008). Using full matching to estimate causal effects in nonexperimentalstudies Examining the relationship between adolescent marijuana use and adultoutcomes.Developmental P sychology,44(2), 395-406.doihttp//dx.doi.org/10.1037/0012-1649.44.2.395Tait, R. J., Mackinnon, A., &Christensen, H. (2011). Cannabis use and cognitive function 8year trajectoryin a young adult cohort.Addiction,106(12), 2195-2203.doihttp//dx.doi.org/10.1111/j.1360-0443.2011.03574.xTapert, S. F., Granholm, E., Leedy, N.G., & Brown, S. A. (2002). Substance use and withdrawal Neuropsychologicalfunctioning over 8 years in youth.Journal of the InternationalNeuropsychological Society,8(7), 873-883.doihttp//dx.doi.org/10.1017/S1355617702870011Van Gundy, K., & Rebellon, C. J.(2010). A life-course perspective on the gateway hypothesis.Journalof Health and Social Behavior,51(3), 244-59. Retrieved fromhttp//proxyiub.uits.iu.edu/login?url=https//search.proquest.com/docview/755695027?accountid=11620van Laar, M., van Dorsselaer, S.,Monshouwer, K., & de Graaf, R. (2007). Does cannabis use predict the firstincidence of mood and anxiety disorders in the adult population?Addiction,102(8),1251-1260.doi http//dx.doi.org.proxyiub.uits.iu.edu/10.1111/j.1360-0443.2007.01875.xVanOs, J., Bak, M., Hanssen, M., Bijl, R. V., De Graaf, R., & Verdoux, H.(2002). Cannabis use and psychosis a longitudinal population-basedstudy.American journal of epidemiology,156(4),319-327. doi https//doi.org/10.1093/aje/kwf043Wade, D., Harrigan, S., Edwards, J.,Burgess, P. M., Whelan, G., & McGorry, P. D. (2006). Course of substancemisuse and daily tobacco use in first-episode psychosis.SchizophreniaResearch,81(2-3), 145-150.doihttp//dx.doi.org/10.1016/j.schres.2005.09.010Womack, S. R., Shaw, D. S., Weaver, C.M., & Forbes, E. E. (2016). Bidirectional associations between cannabis useand depressive symptoms from adolescence through early adulthood among at-riskyoung men.Journal of Studies on Alcohol and Drugs,77(2),287-297. doihttp//dx.doi.org.proxyiub.uits.iu.edu/10.15288/jsad.2016.77.287Zamberletti, E., Beggiato, S., Steardo Jr, L., Prini, P., Antonelli,T., Ferraro, L., Rubino, T., & Parolaro, D. (2014). Alt erations ofprefrontal cortex GABAergic transmission in the complex psychotic-likephenotype induced by adolescent delta-9-tetrahydrocannabinol exposure inrats.Neurobiology of disease,63, 35-47.

No comments:

Post a Comment